Insider Title Company Date Price Return Shares Value
Greenleaf Peter Chief Executive Officer Aurinia Pharmaceuticals Inc. (AUPH) 2021-05-11 $10.71 -35.5% 5,125 $54,891
Return Profit / (loss) Cost
Total -35.5% $-19,477 $54,891